Clinical Trial
Published on 22 Apr 2025
Preliminary clinical activity of TP-0903 in relapsed or refractory acute myeloid leukemia with FLT3-ITD mutations
Frontiers in Hematology
doi 10.3389/frhem.2025.1554764
- 133 views
130 Publications
Volume 4 - 2025
Mini Review
Accepted on 14 Apr 2025
Erythroblast Island Macrophages and Their Surface Markers
Frontiers in Hematology
doi 10.3389/frhem.2025.1580621
Review
Published on 14 Apr 2025
Metabolic reprogramming of fetal hematopoietic stem and progenitor cells by maternal obesity
Frontiers in Hematology
doi 10.3389/frhem.2025.1575143
- 203 views
Original Research
Accepted on 10 Apr 2025
Disease and treatment burden in patients with leukemia: family members/partner perspective
Frontiers in Hematology
doi 10.3389/frhem.2025.1570055
Original Research
Published on 09 Apr 2025
Anemia and its predictors among neonates at Wachemo University teaching hospital, Central Ethiopia: a facility-based cross-sectional study
Frontiers in Hematology
doi 10.3389/frhem.2025.1550664
- 281 views
Original Research
Accepted on 07 Apr 2025
Mogamulizumab in combination improves clinical outcomes in relapsed and refractory SĂ©zary syndrome
Frontiers in Hematology
doi 10.3389/frhem.2025.1557641
Brief Research Report
Published on 03 Apr 2025
Assessing maternal and perinatal complication incidence in pregnant patients with sickle cell disease: a retrospective analysis of transfusion therapy at a tertiary care hospital
Frontiers in Hematology
doi 10.3389/frhem.2025.1549241
- 319 views
Case Report
Accepted on 28 Mar 2025
Teclistamab in the treatment of idiopathic immune thrombocytopenia in patients with multiple myeloma
Frontiers in Hematology
doi 10.3389/frhem.2025.1547209
- 156 views
Original Research
Published on 21 Mar 2025
Cochrane’s contribution to global health: three decades of progress in sickle cell disease research
Frontiers in Hematology
doi 10.3389/frhem.2025.1535100
- 300 views
Review
Published on 21 Mar 2025
Exercise and diet studies among patients living with multiple myeloma: current evidence and considerations of patient preferences
Frontiers in Hematology
doi 10.3389/frhem.2025.1550681
- 803 views
Original Research
Published on 17 Mar 2025
HPLC first approach in detecting thalassemia and other common hemoglobinopathies is more cost and time effective
Frontiers in Hematology
doi 10.3389/frhem.2025.1461498
- 633 views
Case Report
Published on 04 Mar 2025
Case Report: Triplet combination with pirtobrutinib/venetoclax/rituximab in accelerated phase of chronic lymphocytic leukemia
Frontiers in Hematology
doi 10.3389/frhem.2025.1552200
- 633 views
Editorial
Published on 04 Mar 2025
Editorial: Hematopoietic stress in stem cell homeostasis and disease pathogenesis
Frontiers in Hematology
doi 10.3389/frhem.2025.1571674
- 349 views
Review
Published on 03 Mar 2025
Abnormalities of primary and secondary hemostasis in multiple myeloma: insights from studies on thrombopoiesis, the coagulation system, and the bone marrow microenvironment
Frontiers in Hematology
doi 10.3389/frhem.2025.1435193
- 642 views
Original Research
Published on 27 Feb 2025
FACIT-Fatigue scale in patients with cold agglutinin disease: psychometric validation and estimation of clinically meaningful change
Frontiers in Hematology
doi 10.3389/frhem.2025.1490130
- 483 views
Case Report
Published on 26 Feb 2025
Acquired von Willebrand disease associated with smoldering multiple myeloma and hereditary hemorrhagic telangiectasia successfully treated with daratumumab, pomalidomide, and dexamethasone: hitting three birds with one stone? – case report
Frontiers in Hematology
doi 10.3389/frhem.2025.1499500
- 483 views